CompletedNot applicable

Dancing for Better Aging: Evaluating the Impact of a Dance/Movement Therapy (D/MT) Program for Older Adults

NCT02455258 · Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal

Closed to entry

Status

Not accepting participants

Not applicable

Phase

Target enrolment

Study sites

Outside the US

What it is testing

Summary

The aim of this study is to empirically evaluate the impact of a Dance/Movement Therapy program adapted to older adults. Participants over 60 years old are enrolled in one of three groups: Dance/Movement Therapy, Aerobic Exercise or Waiting List (control group) for 12 weeks. The training groups occur 3 times a week for 1 hour each session. Physical condition, cognitive function, general health and lifestyle, and stress hormones are assessed at baseline, after 12 weeks and after 28 weeks.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

Z-score change on Cognitive Functioning
Measured over 0, 12 and 28 weeks

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

60 Years

Ages

All

Sex

Not accepted

Healthy volunteers

Inclusion Criteria: * aged 60 years and older * sedentary or moderately sedentary (less than 150 minutes of moderate to vigorous exercise per week) * have not participated in another similar study in the last year * have not been exposed to a dance or dance/movement therapy program in the past year * are not in a wheelchair * have not had surgery in the past year * have not smoked in the past 5 years * do not consume more than 2 glasses a day of alcohol * are not in treatment for major depression Exclusion Criteria: * progressive neurological disorder * unstable medical conditions (unstable cardio illness in the past 6 months, cardiac or thyroid troubles or pituitary gland illness) * contraindication for moderate physical activity (major orthopaedic limitations) * suspicion of cognitive problems (score of 24 or less on the Mini-Mental State Examination) * large uncorrected perceptual limits * treatment of hormone therapy * uncontrolled hearing loss

Where

1 study site

Facility	City	Region	Country
IUGM	Montreal	Quebec	Canada

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT02455258 on ClinicalTrials.gov →

Last updated in the registry 2016-07-27. Registry records change; this page reflects the data build of 2026-08-25.

Where this trial sits

Substance

Indication

Aging3